& 2019 ($B) 0.3 ~20% ~20% ~60% ~40% ~30% ~30% Total Capex related to year 2018 & 2019 ($B) 1.8 Simple payback of approved projects in 2019 ~4.5 years Notes: a) Out of $1.8B capex, $764M is spent already by
prior to the date on which the Company’s Board of Directors has approved to dispose ordinary shares in NINE, comprising three transactions as follows: (1) the transaction of the disposal of all
, mainly due to new debentures’ issuance in late 2019. ● On March 26,2020, the Company’s Board of Directors’ Meeting approved payment of an interim dividend Baht of 1.05 per share, totaling Baht 3,394
meeting. If one of them transactions does not be approved by the shareholders, it means that both transactions do not be passed the approval from shareholders. The Company; therefore, must disclose the
amount of Baht 445 million as the Company had issued new debentures in late 2019. ● On March 26,2020, the Company’s Board of Directors’ Meeting approved payment of an interim dividend Baht of 1.05 per
จา้งใหด้าํเนินการตาม Distribution Agreement และค่าตอบแทนการขายผลิตภณัฑข์องบริษทัในช่องทางร้านขายยาอิสระจาํนวนรวมประมาณ 22.63 ลา้นบาท เพิม่ข้ึนจากงวดเดียวกนัของปีก่อน จาํนวน 19.44 ลา้นบาท (เร่ิมวา่จา้งซิลลิค
Exercise and Physical Therapy Band; while foreign sales increased slightly, domestic sales were sluggish. However, the Company has increased online distribution channels to facilitate customers. The products